These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38649284)

  • 21. Altered ethanol metabolism and increased oxidative stress enhance alcohol-associated liver injury in farnesoid X receptor-deficient mice.
    Morel C; Chowdhary V; Thevkar Nagesh P; Ribeiro M; Hawryluk D; Catalano D; Adorini L; Szabo G
    Liver Int; 2023 Jan; 43(1):100-114. PubMed ID: 35869657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary tomato powder inhibits alcohol-induced hepatic injury by suppressing cytochrome p450 2E1 induction in rodent models.
    Stice CP; Liu C; Aizawa K; Greenberg AS; Ausman LM; Wang XD
    Arch Biochem Biophys; 2015 Apr; 572():81-88. PubMed ID: 25592162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal effects of ethanol consumption on energy homeostasis, hepatic steatosis, and insulin sensitivity in mice.
    Carr RM; Dhir R; Yin X; Agarwal B; Ahima RS
    Alcohol Clin Exp Res; 2013 Jul; 37(7):1091-9. PubMed ID: 23398239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
    Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy for alcoholic liver disease.
    Jaurigue MM; Cappell MS
    World J Gastroenterol; 2014 Mar; 20(9):2143-58. PubMed ID: 24605013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1.
    Rodríguez-Agudo R; González-Recio I; Serrano-Maciá M; Bravo M; Petrov P; Blaya D; Herranz JM; Mercado-Gómez M; Rejano-Gordillo CM; Lachiondo-Ortega S; Gil-Pitarch C; Azkargorta M; Van Liempd SM; Martinez-Cruz LA; Simão AL; Elortza F; Martín C; Nevzorova YA; Cubero FJ; Delgado TC; Argemi J; Bataller R; Schoonjans K; Banales JM; Castro RE; Sancho-Bru P; Avila MA; Julve J; Jover R; Mabe J; Simon J; Goikoetxea-Usandizaga N; Martínez-Chantar ML
    JHEP Rep; 2024 Jan; 6(1):100918. PubMed ID: 38192540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury
    Pi A; Jiang K; Ding Q; Lai S; Yang W; Zhu J; Guo R; Fan Y; Chi L; Li S
    Front Pharmacol; 2021; 12():752148. PubMed ID: 34603062
    [No Abstract]   [Full Text] [Related]  

  • 29. Involvement of hepatic innate immunity in alcoholic liver disease.
    Byun JS; Jeong WI
    Immune Netw; 2010 Dec; 10(6):181-7. PubMed ID: 21286378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic overexpression of CTRP3 prevents alcohol-induced hepatic triglyceride accumulation.
    Trogen G; Bacon J; Li Y; Wright GL; Degroat A; Hagood KL; Warren Z; Forsman A; Kilaru A; Clark WA; Peterson JM
    Am J Physiol Endocrinol Metab; 2018 Nov; 315(5):E949-E960. PubMed ID: 29763374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic Alcohol Consumption Causes Liver Injury in High-Fructose-Fed Male Mice Through Enhanced Hepatic Inflammatory Response.
    Song M; Chen T; Prough RA; Cave MC; McClain CJ
    Alcohol Clin Exp Res; 2016 Mar; 40(3):518-28. PubMed ID: 26858005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research.
    Neuman MG; Seitz HK; French SW; Malnick S; Tsukamoto H; Cohen LB; Hoffman P; Tabakoff B; Fasullo M; Nagy LE; Tuma PL; Schnabl B; Mueller S; Groebner JL; Barbara FA; Yue J; Nikko A; Alejandro M; Brittany T; Edward V; Harrall K; Saba L; Mihai O
    Biomedicines; 2020 Mar; 8(3):. PubMed ID: 32197424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice.
    Chen WY; Zhang J; Ghare S; Barve S; McClain C; Joshi-Barve S
    Cell Mol Gastroenterol Hepatol; 2016 Sep; 2(5):685-700. PubMed ID: 28119953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
    Kim HG; Huang M; Xin Y; Zhang Y; Zhang X; Wang G; Liu S; Wan J; Ahmadi AR; Sun Z; Liangpunsakul S; Xiong X; Dong XC
    J Hepatol; 2019 Nov; 71(5):960-969. PubMed ID: 31295533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prunella vulgaris L. attenuates gut dysbiosis and endotoxin leakage against alcoholic liver disease.
    Rao PL; Shen YH; Song YJ; Xu Y; Xu HX
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117237. PubMed ID: 37769885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
    Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
    Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
    [No Abstract]   [Full Text] [Related]  

  • 37. The micro-743a-3p-GSTM1 pathway is an endogenous protective mechanism against alcohol-related liver disease in mice.
    Xu T; Pan Y; Ding Q; Cao F; Chang K; Qiu J; Zhuge H; Hao L; Wei H; Si C; Dou X; Li S
    Cell Mol Biol Lett; 2024 Mar; 29(1):35. PubMed ID: 38475733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol effects on hepatic lipid metabolism.
    Jeon S; Carr R
    J Lipid Res; 2020 Apr; 61(4):470-479. PubMed ID: 32029510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice.
    Zhang M; Kong B; Huang M; Wan R; Armstrong LE; Schumacher JD; Rizzolo D; Chow MD; Lee YH; Guo GL
    Dig Liver Dis; 2018 Oct; 50(10):1068-1075. PubMed ID: 29730159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent.
    Goikoetxea-Usandizaga N; Bravo M; Egia-Mendikute L; Abecia L; Serrano-Maciá M; Urdinguio RG; Clos-García M; Rodríguez-Agudo R; Araujo-Legido R; López-Bermudo L; Delgado TC; Lachiondo-Ortega S; González-Recio I; Gil-Pitarch C; Peña-Cearra A; Simón J; Benedé-Ubieto R; Ariño S; Herranz JM; Azkargorta M; Salazar-Bermeo J; Martí N; Varela-Rey M; Falcón-Pérez JM; Lorenzo Ó; Nogueiras R; Elortza F; Nevzorova YA; Cubero FJ; Saura D; Martínez-Cruz LA; Sabio G; Palazón A; Sancho-Bru P; Elguezabal N; Fraga MF; Ávila MA; Bataller R; Marín JJG; Martín F; Martínez-Chantar ML
    Hepatology; 2023 Sep; 78(3):878-895. PubMed ID: 36745935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.